Reviewer’s report
Title: 
Chemotherapy-based gonadotoxicity risk evaluation as a predictor of
reproductive outcomes in cancer survivors: A prospective cohort
Version: 
0 
Date: 
26 Nov 2019
Reviewer's report:
The main title refers the study as a prospective cohort, although in the methods
states and describe a retrospective cohort study in which patients were contacted
regarding the outcome.
Page 5, line 3
What are the main OTCP disadvantages? A brief description of the procedures
could illustrate its advantages to readers.
In the manuscript it should be stated all patients addressed were female. Could
you please state the reasons why the study was designed to address only female
patients up to OTCP, or perhaps why male gonadotoxicity was no addressed ?
Page 12, line 6:
"IVF success rates were low on high risk patients" - would be interesting to
further discuss possible reasons why this occurred
Are the methods appropriate and well described?
If not, please specify what is
required in your comments to the authors.
Yes
Does the work include the necessary controls?
If not, please specify which
controls are required in your comments to the authors.
Unable to assess
Are the conclusions drawn adequately supported by the data shown?
If not,
please explain in your comments to the authors.
Yes
Are you able to assess any statistics in the manuscript or would you
recommend an additional statistical review?
If an additional statistical review
is recommended, please specify what aspects require further assessment in your
comments to the editors.
I am able to assess the statistics
Quality of written English
Please indicate the quality of language in the
manuscript:
Acceptable
Declaration of competing interests
Please complete a declaration of competing
interests, considering the following questions:
1
. 
Have you in the past five years received reimbursements, fees, funding, or
salary from an organisation that may in any way gain or lose financially
from the publication of this manuscript, either now or in the future?
2
. 
Do you hold any stocks or shares in an organisation that may in any way
gain or lose financially from the publication of this manuscript, either now
or in the future?
3
. 
Do you hold or are you currently applying for any patents relating to the
content of the manuscript?
4
. 
Have you received reimbursements, fees, funding, or salary from an
organization that holds or has applied for patents relating to the content of
the manuscript?
5
. 
Do you have any other financial competing interests?
6
. 
Do you have any non-financial competing interests in relation to this
paper?
If you can answer no to all of the above, write 'I declare that I have no competing
interests' below. If your reply is yes to any, please give details below.
'I declare that I have no competing interests'
I agree to the open peer review policy of the journal. I understand that my name
will be included on my report to the authors and, if the manuscript is accepted
for publication, my named report including any attachments I upload will be
posted on the website along with the authors' responses. I agree for my report to
be made available under an Open Access Creative Commons CC-BY license
(
http://creativecommons.org/licenses/by/4.0/
). I understand that any comments
which I do not wish to be included in my named report can be included as
confidential comments to the editors, which will not be published.
I agree to the open peer review policy of the journal